Who founded Tamarind Bio?

Tamarind Bio was founded by Deniz Kavi, Sherry Liu in 2023.

Who are Tamarind Bio's investors?

Tamarind Bio's investors include Eight Capital, Lynett Capital Partners, Transpose Platform Management, Treeo VC, Y Combinator, 468 Capital, 6 Dimensions Capital, Dimension Capital and 1 more.

How much funding has Tamarind Bio raised?

Tamarind Bio has disclosed $27.2M raised across 2 rounds.

Where is Tamarind Bio headquartered?

Tamarind Bio is headquartered in San Francisco, US.

Tamarind Bio

YC W24

San Francisco, US · Founded 2023 · Delaware corporation · 20 employees · Hiring · 9 known investors

Find your way into Tamarind Bio

Paths you didn't know you had: your email and LinkedIn already hold routes to the Tamarind Bio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules. The platform integrates state-of-the-art published tools like AlphaFold and RFdiffusion through a user-friendly interface for life sciences companies.

AI & Machine Learning Biotech Deep Tech Enterprise Software SaaS AI-powered Drug Discovery Artificial Intelligence B2BUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W24)

Tamarind Bio was founded in 2023 by Deniz Kavi and Sherry Liu.

Deniz Kavi Co-Founder & CEOCo-founder and CEO of Tamarind Bio, which provides a computational platform for protein and molecular engineering.

Sherry Liu Co-Founder & CTOSherry Liu studied computer science at Stanford and previously worked as a machine learning researcher at Stanford and at AWS. She is now building computational biology tools at Tamarind Bio.

Recruiting Tamarind BioRecruiter

Abraham PenuelasTechnical Recruiter

Brooke LacinaRecruiterformer

Investors · 9

Eight Capitallisted by Eight CapitalNorwalk

How we know: Y Combinator's founder network · Not right? Tell us

Lynett Capital Partnerslisted by Lynett Capital PartnersJupiter

How we know: Y Combinator's founder network · Not right? Tell us

Transpose Platform Managementlisted by Transpose Platform ManagementSan Francisco

How we know: Transpose Platform Management's portfolio page · Y Combinator's founder network · Not right? Tell us

Treeo VClisted by Treeo VCSan Francisco

How we know: Treeo VC's portfolio page · a partner's Signal profile · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · genengnews.com · open dataset · 5k.vc investor directory · Not right? Tell us

468 CapitalreportedBerlin

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

6 Dimensions CapitalreportedGrand Cayman

How we know: a partner's Signal profile · Not right? Tell us

Dimension CapitalreportedSan Francisco · $1M – $10M

How we know: funding news · genengnews.com · Y Combinator's founder network · Not right? Tell us

RunwayreportedNew York City

How we know: Y Combinator's founder network · Not right? Tell us

Funding

SEC filings, press & company announcements

$27.2M disclosed across 2 rounds · 2025–2026

$13.6MSeries AFeb 2026
Dimension Capital (lead), Y Combinator
Source ↗

▶$13.6MraisedMay 2025 · 24 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

SHERRY LIUExecutive Officer, Director
DENIZ KAVIExecutive Officer, Director

Offering amount: $13.6M
Amount sold: $13.6M
First sale: May 2025
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 8

OriginOrigin generates spatial molecular maps from patient tumor samples to enable cancer biology research in native tissue context. The platform combines spatial transcriptomics, imaging, and functional perturbation assays on fresh and archived tumors, paired with AI models for drug response prediction and target discovery.

Ångström AIÅngström AI develops AI-powered physics simulations for pharmaceutical drug discovery, computing molecular properties like solubility, lipophilicity, and crystal structure stability to replace traditional lab experiments. The platform uses machine learning interatomic potentials and free energy calculations to accelerate and derisk solid form development for pharma companies.

Evolvere BioSciencesEvolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.

OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.

GloGlo14.ai builds software that automates the core operations of e-commerce brands, handling customer acquisition, order fulfillment, and support with minimal human intervention, and uses the platform to operate its own direct-to-consumer business.

Paceline BioPlay Health builds a clinical decision-support platform for healthcare providers to deliver personalized menopause and women's health care. The platform serves primary care physicians and other providers treating women navigating perimenopause and menopause.

Hugging FaceHugging Face is a collaboration platform that hosts and provides access to machine learning models, datasets, and applications. It offers both open-source tools for the ML community and paid compute and enterprise solutions for teams building AI applications.

NVIDIANVIDIA designs GPUs, AI computing hardware, and software platforms for AI development, data centers, autonomous vehicles, and robotics, serving developers, researchers, and enterprises. Its offerings include AI models, power architecture for AI factories, and compute infrastructure used across industries such as manufacturing, healthcare, and automotive.

Companies working in the same space as Tamarind Bio.

Legal entities · 1

corporate structure

Tamarind Bio, Inc.

In the news

Tamarind Bio: API for scalable bioinformaticsycombinator.com · Feb 2024

Tamarind Bio: No-code bioinformatics for scientistsycombinator.com · Dec 2023

Tamarind Bio Funding | Complete Analysis | Extruct AIextruct.ai

Frequently asked questions

What does Tamarind Bio do?: Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules. The platform integrates state-of-the-art published tools like AlphaFold and RFdiffusion through a user-friendly interface for life sciences companies.
Who founded Tamarind Bio?: Tamarind Bio was founded by Deniz Kavi, Sherry Liu in 2023.
Who are Tamarind Bio's investors?: Tamarind Bio's investors include Eight Capital, Lynett Capital Partners, Transpose Platform Management, Treeo VC, Y Combinator, 468 Capital, 6 Dimensions Capital, Dimension Capital and 1 more.
How much funding has Tamarind Bio raised?: Tamarind Bio has disclosed $27.2M raised across 2 rounds.
Where is Tamarind Bio headquartered?: Tamarind Bio is headquartered in San Francisco, US.